CSI Market
Sign In | Register

Biosynergy Inc (BSYN) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BSYN Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Biosynergy Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jan 31 2022)
9 Months 		(Oct 31 2021) (Jul 31 2021) (Apr 30 2021) (Jan 31 2021)
Operating Activities
Income-0.70
Depreciation & amortization0.01
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.04
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property-1.24
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Noncash Lease Expense0.08
Increase Decrease In Inventories Prepaid Expenses And Other-
Increase Decrease In Operating Lease Liability-0.08
Income taxes-0.02
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.02
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.21
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.01
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.66
Discontinued operations0.00
Net Cash flow from Operating Activities-0.12
Investing Activities
Capital Expenditures1.50
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments For Proceeds From Collection Of Advance To Affiliate-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.15
Discontinued operations0.00
Net Cash Flow from Investing Activities1.35
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1.38
Total Cash Flow1.23
4 historic quarters locked

Sign in to unlock the full Biosynergy Inc cash flow history.

Sign In Create Free Account

About Biosynergy Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-22-007349

Figures are derived from filed reports and may be restated. Historical data is subject to revision.